Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Axicabtagene Ciloleucel, for the Treatment of Large B-Cell Lymphoma in the United States

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [1] Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma A Review
    Locke, Frederick L.
    Go, William Y.
    Neelapu, Sattva S.
    JAMA ONCOLOGY, 2020, 6 (02) : 281 - 290
  • [2] Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)
    Pasquini, Marcelo C.
    Locke, Frederick L.
    Herrera, Alex F.
    Siddiqi, Tanya
    Ghobadi, Armin
    Komanduri, Krishna V.
    Hu, Zhen-Huan
    Dong, Hua
    Hematti, Peiman
    Nikiforow, Sarah
    Steinert, Patricia
    Purdum, Anna
    Horowitz, Mary M.
    Hooper, Michelle
    Kawashima, Jun
    Jacobson, Caron A.
    BLOOD, 2019, 134
  • [3] Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma: Practical Implications for the Community Oncologist
    Jacobson, Caron A.
    Farooq, Umar
    Ghobadi, Armin
    ONCOLOGIST, 2020, 25 (01): : E138 - E146
  • [4] Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Hill, Brian T.
    Roth, Caroline J.
    Kositsky, Rachel
    Dave, Tushar
    Love, Cassandra
    McKinney, Matthew
    Galal, Ahmed
    Neff, Jadee L.
    Mian, Agrima
    Kendall, Ellen
    Ondrejka, Sarah L.
    Chiaramonte, Matthew
    Bhagat, Govind
    Ofori, Kenneth
    Reshef, Ran
    Kovach, Alexandra E.
    Sethi, Tarsheen
    Mason, Emily F.
    Bhaskar, Shakthi
    Oluwole, Olalekan O.
    Pallas, Christopher
    Ghosh, Nilanjan
    Ferdman, Robert
    Chen, George L.
    Hernandez-Ilizaliturri, Francisco J.
    Zurko, Joanna C.
    Cunningham, Ashley
    Shah, Nirav N.
    Hu, Boyu
    Stephens, Deborah M.
    Ghosh, Monalisa
    Bailey, Neil
    Patel, Krish
    Pagel, John M.
    Kannan, Kavya Kannamma
    Hsi, Eric D.
    Vaidya, Rakhee
    Ip, Andrew
    Goy, Andre H.
    Kambhampati, Swetha
    Ohgami, Robert S.
    Andreadis, Charalambos
    Thacker, Elizabeth
    Rozzi, Chrissie
    Parker, Clay
    Happ, Lanie
    Dave, Sandeep S.
    BLOOD, 2021, 138
  • [5] Axicabtagene Ciloleucel CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World Experience
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (02) : 13 - 15
  • [6] Axicabtagene Ciloleucel CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real-World Experience
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 9 - 10
  • [7] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
    Rapoport, Aaron P.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 1019 - 1020
  • [8] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
    Rapoport, Aaron P.
    HAEMATOLOGICA, 2024, 109 (04) : 1019 - 1020
  • [9] Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study
    Tun, Aung M.
    Patel, Romil D.
    St-Pierre, Frederique
    Ouchveridze, Evguenia
    Niu, Alex
    Thordardottir, Thorunn
    Obasi, Jennifer
    Rosenthal, Allison
    Pophali, Priyanka A.
    Fenske, Timothy S.
    Karmali, Reem
    Ahmed, Sairah
    Johnston, Patrick B.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (09) : 1712 - 1720
  • [10] Clinical development of anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
    Makita, Shinichi
    Yoshimura, Kiyoshi
    Tobinai, Kensei
    CANCER SCIENCE, 2017, 108 (06) : 1109 - 1118
12345